Skip to main content
Clinical Trials/NCT02082470
NCT02082470
Completed
N/A

Feasibility and Preliminary Outcomes of Survivorship Care Planning in Ovarian Cancer

City of Hope Medical Center1 site in 1 country14 target enrollmentApril 11, 2014

Overview

Phase
N/A
Intervention
Not specified
Conditions
Cancer Survivor
Sponsor
City of Hope Medical Center
Enrollment
14
Locations
1
Primary Endpoint
Recruitment rates
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

This pilot clinical trial studies survivorship care planning in supporting quality of life in ovarian cancer survivors following primary treatment. Survivorship care plans have the potential to empower patients and provide them with a plan of care following treatments. Survivorship care planning may support patient's overall well-being and quality of life after treatment of ovarian cancer.

Detailed Description

PRIMARY OBJECTIVES: I. To assess the feasibility and acceptability of survivorship care planning (SCP) in ovarian cancer. SECONDARY OBJECTIVES: I. To develop the infrastructure and strategy for a larger comparative intervention study (National Cancer Institute \[NCI\] R01). OUTLINE: Participants are assigned to 1 of 2 arms. ARM I: Participants receive standard post-treatment care consisting of regular cancer surveillance visits with treating oncologists. ARM II: Participants complete survivorship care planning in close collaboration with treating oncologists. After completion of study treatment, participants are followed up at 2 months.

Registry
clinicaltrials.gov
Start Date
April 11, 2014
End Date
September 26, 2017
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
City of Hope Medical Center
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of stage I, II, or III ovarian cancer
  • Ability to read or understand English
  • All subjects must have the ability to understand and the willingness to sign a written informed consent

Exclusion Criteria

  • Subjects, who in the opinion of the investigator, may not be able to comply with the safety monitoring requirements of the study

Outcomes

Primary Outcomes

Recruitment rates

Time Frame: 2 months

Important information regarding recruitment for the subsequent larger trial will be provided including estimates of the number of contacts needed to produce a qualified participant, the percentage of those who are qualified and agree to participate, and a retention rate.

Patient satisfaction assessed using the Survivor Satisfaction Tool and Debriefing Form

Time Frame: 2 months

Quantitative and qualitative descriptive statistics will be analyzed using descriptive statistics and content analysis methods to determine satisfaction with the timing, content, and delivery of the intervention.

Percentage of attrition

Time Frame: 2 months

Descriptive statistics will be presented on those who agree to participate and the proportion of those approached who agree to participate. Descriptive statistics will also be presented for percentage of attrition (based on number of patients who failed to complete the 2 months study. Reasons for attrition will also be documented.

Total retention

Time Frame: 2 months

Descriptive statistics will be presented for the total retention.

Secondary Outcomes

  • Infrastructure for a larger comparative intervention study(2 months)

Study Sites (1)

Loading locations...

Similar Trials

Completed
N/A
Carevive Survivor Care Planning System in Improving Quality of Life in Breast Cancer SurvivorsStage I Breast CancerStage I Cervical CancerStage I Ovarian CancerStage I Uterine Corpus CancerStage IA Breast CancerStage IA Cervical CancerStage IA Ovarian CancerStage IA Uterine Corpus CancerStage IB Breast CancerStage IB Cervical CancerStage IB Ovarian CancerStage IB Uterine Corpus CancerStage IC Ovarian CancerStage II Breast CancerStage II Cervical CancerStage II Ovarian CancerStage II Uterine Corpus CancerStage IIA Breast CancerStage IIA Cervical CancerStage IIA Ovarian CancerStage IIB Breast CancerStage IIB Cervical CancerStage IIB Ovarian CancerStage IIC Ovarian CancerStage III Breast CancerStage III Cervical CancerStage III Ovarian CancerStage III Uterine Corpus CancerStage IIIA Breast CancerStage IIIA Cervical CancerStage IIIA Ovarian CancerStage IIIA Uterine Corpus CancerStage IIIB Breast CancerStage IIIB Cervical CancerStage IIIB Ovarian CancerStage IIIB Uterine Corpus CancerStage IIIC Breast CancerStage IIIC Ovarian CancerStage IIIC Uterine Corpus Cancer
NCT03198286Sidney Kimmel Cancer Center at Thomas Jefferson University40
Completed
N/A
Enhancing Survivorship Care Planning for Patients With Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management ProgramProstate Cancer
NCT04350788UNC Lineberger Comprehensive Cancer Center124
Active, Not Recruiting
N/A
Survivorship Care Planning in Improving the Quality of Life in Breast Cancer SurvivorsBreast CancerCancer Survivor
NCT01824745City of Hope Medical Center100
Completed
Phase 2
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in ChildrenRecurrent Brain TumorsSupratentorial PNETsMedulloblastomasEpendymomas
NCT00749723University Hospital, Bonn174
Recruiting
N/A
Lifestyles Implemented-Survivorship Care Plan In Lymphoma SurvivorsClassical Hodgkin LymphomaDiffuse Large B Cell Lymphoma (DLBCL)Primary Mediastinal Large B-cell Lymphoma (PMBCL)
NCT05934084Fondazione Italiana Linfomi - ETS552